Clinical Trials Sponsored by David Iberri

Total 1641 results

Polak David

Unknown

Polymorphonuclear Cells' Sensitivity to Aggregatibacter Actinomycetemcomitans Bacteria in Patients With Aggressive Periodontitis

Periodontal Disease

Israel
King, David, MD
MERZ PHARMA

Not yet recruiting

Whiplash-induced Thoracic Outlet Syndrome Treated With Botulinum Toxin.

Whiplash Injuries | Thoracic Outlet Syndrome

Canada
David Mooney

Terminated

Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children

Abdominal Injury

United States
David Miklos
Novartis

Completed

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Graft vs Host Disease

United States
David Smart

Completed

Early Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral Isotretinoin

Acne Scars - Mixed Atrophic and Hypertrophic
Polak David

Unknown

Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs

Peri-implant Mucositis

Israel
David Rizzieri, MD

Completed

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Lymphoma

United States
david groshar

Unknown

PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease

Idiopathic Parkinson's Disease
David Scheiner
University of Zurich

Terminated

A Comparison of the Retropubic (TVT) With the Transobturator Sling Operation in the Treatment of Female Stress Urinary Incontinence or Stress Dominated Mixed Urinary Incontinence

Stress Urinary Incontinence

Switzerland
David Rizzieri, MD

Completed

Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes

Sickle Cell Anemia | Pure Red Cell Aplasia | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Severe Aplastic Anemia

United States
Avid Radiopharmaceuticals

Recruiting

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Neoplasms | Neoplasms Malignant

Australia
Avid Radiopharmaceuticals

Completed

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Alzheimer's Disease
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Terminated

Flortaucipir 18F PET Imaging in BIOCARD Study

Cognitive Decline

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy

United States
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 High Resolution Autopsy Study

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Neurodegenerative Diseases | Alzheimer Disease | Mild Cognitive Impairment

United States
Avid Radiopharmaceuticals

Completed

Florbetapir Calibration to the Centiloid Scale

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Completed

Evaluation of Reader Training Processes

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

The Feasibility of Florbetapir Quantitation in Europe

Alzheimer's Disease

Netherlands
Avid Radiopharmaceuticals

Completed

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

18F-LY3950321-01 Biodistribution and Safety Study

Radiation Exposure | Diagnostic Agent Adverse Reaction

United States
Avid Radiopharmaceuticals

Completed

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Terminated

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

Corticobasal Degeneration | Progressive Supranuclear Palsy

United States
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Patients With Early Symptomatic AD

Alzheimer Disease

United States, Canada
Avid Radiopharmaceuticals

Withdrawn

18F-AV-1451 PET Imaging in TBI

Traumatic Brain Injury

United States
Avid Radiopharmaceuticals

Withdrawn

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

Alzheimer's Disease

Japan
Avid Radiopharmaceuticals

Completed

Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.

Frontotemporal Dementia | Alzheimer's Disease

United Kingdom
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Alzheimers Disease | AD

United States
Avid Radiopharmaceuticals

Completed

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Progressive Cognitive Decline

United States
Avid Radiopharmaceuticals

Completed

A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)

Parkinson's Disease | Alzheimer's Disease | Dementia With Lewy Bodies

United States
Avid Radiopharmaceuticals

Completed

A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Alzheimer's Disease
Avid Radiopharmaceuticals

Completed

A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

United States
David Moss

Recruiting

Acupuncture for Chronic Pelvic Pain

Pelvic Pain | Acupuncture | Gynecology

United States
David D'Andrea

Not yet recruiting

Single-Dose Intravesical Chemotherapy After Diagnostic URS (MINERVA)

Bladder Cancer | Upper Urinary Tract Urothelial Carcinoma

Austria
David Palma

Recruiting

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. (SABR-SYNC)

Metastatic Tumor

Canada
DAVID DESSEAUVE

Not yet recruiting

Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia (RIPC)

Preeclampsia
David Chi, MD

Terminated

Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity

Analgesia | Surgery | Adenotonsillectomy

United States
David Jang, M.D.
Amgen

Completed

Erenumab for Idiosyncratic Facial Pain

Facial Pain | Rhinosinusitis

United States
David Bajor

Active, not recruiting

CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Solid Tumor | Colon Cancer

United States
David Haines, MD

Terminated

Left Bundle Area Versus Selective His Bundle Pacing (LEFTBASH)

Bradycardia | Atrioventricular Block | Sinus Node Dysfunction

United States
David Clarke
Nova Scotia Health Authority

Completed

Assessment of the Efficacy of Stereotactic Intracavitary Instillation of 90Yttrium Colloid

Neuroepithelial Cyst

Canada
David Peran

Enrolling by invitation

Causes of Traffic Collisions of Ambulance Cars at the Prague Emergency Medical Services

Traffic Collision | Transport Accident

Czechia
David Travis Thomas

Completed

Vitamin D for Muscle Metabolic Function in Cancer Cachexia

Vitamin D Deficiency | Cancer Cachexia

United States

Clinical Trials Sponsored by David Iberri

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations